nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinitapride—HTR4—Amine ligand-binding receptors—TAAR6—cervical cancer	0.231	0.231	CbGpPWpGaD
Cinitapride—HTR4—G alpha (s) signalling events—TAAR6—cervical cancer	0.0955	0.0955	CbGpPWpGaD
Cinitapride—HTR1A—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0737	0.0737	CbGpPWpGaD
Cinitapride—HTR2A—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0636	0.0636	CbGpPWpGaD
Cinitapride—HTR2A—Serotonin Receptor 2 and STAT3 Signaling—STAT3—cervical cancer	0.061	0.061	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0455	0.0455	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—TAAR6—cervical cancer	0.0347	0.0347	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—WNT2—cervical cancer	0.0271	0.0271	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—WNT5A—cervical cancer	0.0205	0.0205	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—TAAR6—cervical cancer	0.0196	0.0196	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—TAAR6—cervical cancer	0.0178	0.0178	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0145	0.0145	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—WNT2—cervical cancer	0.0139	0.0139	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—AKAP13—cervical cancer	0.0134	0.0134	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0125	0.0125	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—AKAP13—cervical cancer	0.0122	0.0122	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—TAAR6—cervical cancer	0.011	0.011	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—WNT5A—cervical cancer	0.0105	0.0105	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TAAR6—cervical cancer	0.0105	0.0105	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—TAAR6—cervical cancer	0.00953	0.00953	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—WNT2—cervical cancer	0.00861	0.00861	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00861	0.00861	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—WNT2—cervical cancer	0.0082	0.0082	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—WNT2—cervical cancer	0.00744	0.00744	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00744	0.00744	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—AKAP13—cervical cancer	0.0072	0.0072	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—WNT5A—cervical cancer	0.00653	0.00653	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—TAAR6—cervical cancer	0.00624	0.00624	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—WNT5A—cervical cancer	0.00622	0.00622	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—TAAR6—cervical cancer	0.00566	0.00566	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—WNT5A—cervical cancer	0.00564	0.00564	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—TAAR6—cervical cancer	0.00539	0.00539	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—TAAR6—cervical cancer	0.00489	0.00489	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.00448	0.00448	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—WNT2—cervical cancer	0.00442	0.00442	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—NOTCH2—cervical cancer	0.00436	0.00436	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.00432	0.00432	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—AKAP13—cervical cancer	0.00427	0.00427	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—AKAP13—cervical cancer	0.00388	0.00388	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.00387	0.00387	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—WNT2—cervical cancer	0.00382	0.00382	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.00373	0.00373	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—AKAP13—cervical cancer	0.00369	0.00369	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—HES1—cervical cancer	0.00358	0.00358	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AKAP13—cervical cancer	0.00335	0.00335	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—WNT5A—cervical cancer	0.00335	0.00335	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TAAR6—cervical cancer	0.00334	0.00334	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TERT—cervical cancer	0.00314	0.00314	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—WNT5A—cervical cancer	0.00289	0.00289	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TAAR6—cervical cancer	0.00289	0.00289	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—FGFR3—cervical cancer	0.00288	0.00288	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—NOTCH1—cervical cancer	0.0027	0.0027	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—WNT2—cervical cancer	0.00261	0.00261	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—EGFR—cervical cancer	0.00241	0.00241	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AKAP13—cervical cancer	0.00229	0.00229	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.00229	0.00229	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—WNT2—cervical cancer	0.00226	0.00226	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MTOR—cervical cancer	0.00202	0.00202	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AKAP13—cervical cancer	0.00198	0.00198	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—WNT5A—cervical cancer	0.00198	0.00198	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CASP3—cervical cancer	0.00186	0.00186	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CTNNB1—cervical cancer	0.00179	0.00179	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—WNT5A—cervical cancer	0.00171	0.00171	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—STAT3—cervical cancer	0.00156	0.00156	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—EGFR—cervical cancer	0.00142	0.00142	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NOTCH2—cervical cancer	0.00139	0.00139	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	0.0012	0.0012	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TP53—cervical cancer	0.00119	0.00119	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HES1—cervical cancer	0.00114	0.00114	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TERT—cervical cancer	0.000998	0.000998	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HES1—cervical cancer	0.000984	0.000984	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FGFR3—cervical cancer	0.000916	0.000916	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TERT—cervical cancer	0.000862	0.000862	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	0.00086	0.00086	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FGFR3—cervical cancer	0.000791	0.000791	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—EGFR—cervical cancer	0.000766	0.000766	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	0.000743	0.000743	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—EGFR—cervical cancer	0.000662	0.000662	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MTOR—cervical cancer	0.000644	0.000644	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CASP3—cervical cancer	0.000593	0.000593	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	0.000571	0.000571	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MTOR—cervical cancer	0.000557	0.000557	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CASP3—cervical cancer	0.000512	0.000512	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—STAT3—cervical cancer	0.000498	0.000498	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	0.000493	0.000493	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EGFR—cervical cancer	0.000452	0.000452	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—STAT3—cervical cancer	0.00043	0.00043	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EGFR—cervical cancer	0.000391	0.000391	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TP53—cervical cancer	0.00038	0.00038	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TP53—cervical cancer	0.000328	0.000328	CbGpPWpGaD
